Cullinan Therapeutics

Biotech · Public

Small molecule therapeutics for oncology and autoimmune diseases

cullinantherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
8
1 granted · 7 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2886FEMTOFLUIDICS INCORPORATED——
2887Origin Holdings Inc.—$137M
2888RESVERLOGIX CORP.—$12M
2889Cullinan Therapeutics——
2890Network Music Partners, LLC—$205K
2891Sage Therapeutics—$698M
2892OTHRO THERAPEUTICS, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Press

1 article · matched on company name

Patents

USPTO · 1 granted of 8
  • ANTI-CD19 Antibodies And Multi-specific Binding Proteinsgranted
  • Multi-specific Binding Proteins And Methods Of Use Thereofapplication
  • Anti-serum Albumin Antibodiesapplication
  • Therapies For Autoimmune Disordersapplication
  • Methods Of Use Of Multi-specific Binding Proteinsapplication
  • Methods Of Use Of Multi-specific Binding Proteinsapplication
  • Therapies For Autoimmune Disordersapplication
  • Therapies For Autoimmune Disordersapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.